Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership & nbsp; to develop first in class therapies in autoimmune disease and immuno-oncology

Pathios Therapeutics ("Pathios"), an innovative biotech company focused on the development of first in class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery...
Source: The Scientist - Category: Science Tags: The Marketplace The Scientist Source Type: news